Related by context. All words. (Click for frequent words.) 67 Ischaemic 64 Hormone Refractory Prostate Cancer 63 Systolic Blood Pressure 63 Subgroup Analysis 62 Aggressive Reduction 62 STRIDE PD 62 Thromboembolism 62 Knee Osteoarthritis 62 Peripheral Vascular Disease 62 Osteoporosis Screening 62 Spine Patient Outcomes 62 Restenosis 62 Cholesterol Levels SPARCL 62 Fracture Risk 61 Enlarged Prostate 61 Appears Safe 61 Preterm Delivery 61 Adjuvant Breast Cancer 61 Prospective Randomized 61 Prevent Stroke 61 Carotid Stenting 61 Cardiovascular Outcomes 61 Intracerebral Hemorrhage 61 Improves Outcomes 61 Arrhythmias 60 FASLODEX 60 Improve Survival 60 Ischemic 60 PHPT 60 Beta Blockers 60 Acute Ischemic Stroke 60 Randomized controlled 60 Heart Failure Patients 60 Breast Cancer Recurrence 60 Tiotropium 60 Therapy Shows Promise 60 Therapy Reduces 59 ACE Inhibitor 59 Malignant Melanoma 59 PRoFESS 59 Hydroxyurea 59 Acute Myocardial Infarction 59 Lower Extremity 59 Oral Fingolimod 59 Aortic Stenosis 59 Bone Mineral Density 59 Chronic Heart Failure 59 Rheumatoid Arthritis Patients 59 Randomised 59 Epileptic Seizures 59 Peripheral Arterial 59 Fondaparinux 59 VADT 59 Breast Density 59 Overactive Bladder 59 Radiofrequency Ablation 59 Lung Cancer Trial 59 Pulmonary Artery 59 Combination Treatment 59 Symptom Relief 59 atherosclerotic renal artery stenosis 59 Randomized Study 59 Treating Chronic 59 Antiplatelet Therapy 59 Artery Disease 59 Refractory Angina 59 Coronary Arteries 59 Invasive Breast Cancer 59 Advanced Melanoma 59 Statin Therapy 58 Nonalcoholic Fatty Liver Disease 58 Prolongs Survival 58 Adjuvant Treatment 58 Thrombotic 58 Randomized Clinical Trial 58 Rheumatoid 58 Adjuvant Chemotherapy 58 Liver Metastases 58 Juvenile Idiopathic Arthritis 58 Beta Blocker 58 Coronary Artery Bypass Graft 58 Diabetic Patients 58 Effective Treatments 58 Cognitive Function 58 multicenter randomized controlled 58 Bone Fracture 58 Replacement Therapy 58 Demonstrates Efficacy 58 Lung Injury 58 Patients Undergoing 58 Adenoma Prevention 58 Platelet Inhibition 58 Cognitive Impairment 58 DAPT 58 Benign Prostatic Hyperplasia BPH 58 Cardiovascular Risk 58 Skin Lesions 58 Lowers Risk 58 Relapsing Remitting Multiple Sclerosis 58 Postmenopausal 58 Renal Artery 58 Non Inferiority 58 assessing T DM1 58 Stenting 58 Resistant Hypertension 58 Alteplase 58 Radiofrequency Ablation RFA 58 Ischemic Stroke 58 Phase 2b Study 58 Catheter Ablation 58 Hypotension 58 thromboembolic 58 Breast Cancers 58 Hypertensive Patients 58 Adjunctive 58 AVANDIA 58 Patients Receiving 58 Knee Arthritis 58 Cardiotoxicity 58 Cardiac Resynchronization 58 OVARIAN 58 Complicated Skin 58 Thrombolysis 58 Clinical Relevance 58 See CLINICAL PHARMACOLOGY 57 Hip Fracture Risk 57 Infarction 57 Duodenal 57 Is Well Tolerated 57 LDL Cholesterol 57 Muscle Pain 57 Treatment Shows Promise 57 Aortic Valve 57 Erythropoietic therapies may 57 Myocardial Ischemia 57 HYVET 57 Node Positive 57 Lifestyle Intervention 57 Venous Thromboembolism 57 ACCOMPLISH 57 recurrent venous thromboembolism 57 Orthostatic Hypotension 57 Cerebrovascular Diseases 57 Reduce Cardiovascular 57 Stent Thrombosis 57 Surgical Treatment 57 Nonsurgical 57 CRT ICD 57 artery stenosis 57 Valvular Heart Disease 57 Blood Clots 57 postoperative AF 57 CIMZIA TM certolizumab pegol 57 Colorectal Cancers 57 HIV lipodystrophy 57 Combination REOLYSIN R 57 Randomised Study 57 Antiplatelet 57 Stable Angina 57 clevidipine 57 endometrial hyperplasia 57 Clinical Outcome 57 riociguat 57 Prophylactic Treatment 57 Anticoagulation 57 Colorectal Adenomas 57 Randomized Evaluation 57 multicentre randomized controlled 57 chronic thromboembolic pulmonary 57 Improves Survival 57 Intravitreal 57 Bivalirudin 57 Unstable Angina 57 Interferon Beta 57 Short Stature 57 Randomized Phase II 57 DVT prophylaxis 57 Skeletal Muscle 57 Slow Progression 57 Chronic Sinusitis 57 GOUT 57 Prevent Heart 57 Shows Promise Against 57 Severe Sepsis 57 Insulin Therapy 57 dual endothelin receptor antagonist 57 Myocardial Infarction Study 57 Placebo Controlled 57 Acute Myocardial 57 ACE Inhibitors 57 Confirmatory Phase 57 Liver Failure 57 Kidney Failure 57 Slows Progression 57 Diabetic Foot Ulcer 57 Improve Outcomes 57 Sustained Efficacy 57 Fungal Infections 57 CARE HF 57 Cardiac Resynchronization Therapy 57 Cardiovascular Events 57 β blockers 57 Hip Fractures 57 venous thromboembolic events 57 Recurrent Stroke 57 Dasatinib 57 Patency 57 Inhaled Corticosteroids 56 Tennis Elbow 56 Randomized Controlled Trials 56 Randomized Double blind 56 ribavirin USP 56 Multicenter Randomized 56 Cholesterol Levels 56 Left Ventricular 56 Phase III Clinical Trial 56 Scandinavian Simvastatin Survival 56 Abdominal Aortic Aneurysm 56 Diabetic Neuropathy 56 Reduces Pain 56 Heterozygous Familial Hypercholesterolemia 56 Diuretic 56 Minimally Invasive Treatment 56 Randomized Phase 56 Renal Cell Carcinoma 56 Treating Heart Failure 56 suppurative 56 Venous Thrombosis 56 Randomized Double Blind 56 postoperative mortality 56 Anticoagulant 56 Pediatric Patients 56 Patients Treated With 56 Gum Disease 56 phase IIIb 56 post thrombotic syndrome 56 Kidney Stones 56 Ranolazine 56 Decompensated Heart Failure 56 Hyperlipidemia 56 Relapsing Multiple Sclerosis 56 DEFER 56 Drug Prevents 56 Benign Prostatic Hyperplasia 56 Carotid Artery 56 Sclerosis 56 FDA Approves Drug 56 Phase 2b Clinical Trial 56 Coronary Disease 56 Levels Linked 56 Hormone Replacement 56 Healthbeat Report 56 Soft Tissue Sarcoma 56 Insulin Glargine 56 Pivotal Phase 56 Sipuleucel T 56 Treatment Naive Patients 56 Shows Efficacy 56 AA Amyloidosis 56 unfractionated heparin UFH 56 Diabetic Macular Edema 56 NCT# ClinicalTrials.gov 56 Placebo Controlled Study 56 Fibromyalgia Pain 56 Stress Incontinence 56 Pivotal Trial 56 EINSTEIN DVT 56 Pooled Analysis 56 Therapy Improves 56 registrational Phase 56 Meta Analysis 56 Systemic Sclerosis 56 Unfractionated Heparin 56 Placebo Controlled Trial 56 Periodontal Therapy 56 Hormone Therapy 56 ATACAND 56 Statistically Significant 56 Estrogen Therapy 56 untreated OSA 56 Prospective Multicenter 56 Proteinuria 56 Elderly Patients 56 Sleep Disturbances 56 Low Testosterone 56 Long Term Efficacy 56 Blocked Arteries 56 Lowers Blood Pressure 56 Periodontal Disease 56 Contraindications 56 Myoblast 56 Rotavirus Vaccine 56 Spinal Stenosis 56 Patient Outcomes 56 Proves Effective 56 Diabetic Kidney Disease 56 Improved Survival 56 Endothelial Function 56 Beneficial Effects 56 MADIT II 56 Helicobacter pylori eradication 56 Prostate Cancer Screening 56 Long Term Outcomes 56 Migraine Headaches 56 Investigational Treatment 56 invasive candidiasis 56 Less Invasive 56 Nesiritide 55 icatibant 55 Excessive Sweating 55 Smoking Linked 55 Heel Pain 55 Reduced Risk 55 Interferon Alfa 55 Bone Density 55 Bipolar Depression 55 colesevelam HCl 55 HER2 Positive 55 Cholesterol Lowering Drug 55 Polycystic Ovary Syndrome 55 revascularisation 55 Left Ventricular Hypertrophy 55 Gene Linked 55 ASTEROID 55 Adalimumab 55 Intervention Effectiveness 55 Diastolic Heart Failure 55 Percutaneous Coronary Intervention 55 Advanced Ovarian Cancer 55 subanalysis 55 ST Segment Elevation 55 Genes Linked 55 Premature Infants 55 resynchronization therapy 55 Intervention Trial 55 Monotherapy 55 Advanced Prostate Cancer 55 Valsartan 55 Nonalcoholic Steatohepatitis 55 Acute Decompensated Heart Failure 55 Coronary Artery Bypass Grafting 55 bladder dysfunction 55 placebo controlled clinical 55 clazosentan 55 Dual Antiplatelet Therapy 55 NSABP B 55 Anticoagulants 55 Acute Coronary Syndromes 55 acute gout 55 Raloxifene STAR 55 Stroke Risk 55 Initiated Phase 55 Severe Asthma 55 Peginterferon Alfa 2a 55 oral antidiabetic medication 55 recurrent glioblastoma multiforme 55 Detecting Breast Cancer 55 Implantable Cardioverter Defibrillator 55 Osteoporosis Drugs 55 decompressive surgery 55 Blood Pressure Drug 55 ARBITER 6 55 Xelox 55 Chronic Pelvic Pain 55 Hepatotoxicity 55 Blood Clot Risk 55 Stent Placement 55 Breast Cancer Treatment 55 Cardiovascular Disease Risk 55 carotid endarterectomy CEA 55 Cinacalcet 55 Paroxysmal Nocturnal Hemoglobinuria PNH 55 Avandia Actos 55 Phase III Pivotal Trial 55 Carotid Revascularization Endarterectomy vs. 55 Drug Combo 55 Advanced Renal Cell 55 corticosteroid therapy 55 Patients Suffering 55 prospective multicentre 55 Esophageal Cancer 55 Efficacy Trial 55 nonfatal myocardial infarction MI 55 ARIXTRA 55 Critically Ill Patients 55 Spasticity 55 Pediatric Asthma 55 Cognitive Decline 55 Bloodstream Infections 55 Gestational Diabetes 55 Lung Function 55 Chronic HCV 55 Bronchodilator 55 Radiation Dose 55 GnRH agonists 55 Newly Diagnosed Multiple Myeloma 55 Glycemia 55 Often Misdiagnosed 55 Relieve Pain 55 HPA axis suppression 55 Pharmacodynamics 55 Congestive Heart Failure 55 Schizophrenia Treatment 55 Controlled Trial 55 #mg dosing 55 Implantable Defibrillator 55 Effectively Treats 55 Triptan 55 Nebulized 55 HCV SPRINT 55 HEART FAILURE 55 Telmisartan 55 HCV RESPOND 2 55 ASSERT 55 Deep Vein Thrombosis DVT 55 Magnetic Stimulation 55 Deep Vein Thrombosis 55 Castration Resistant Prostate Cancer 55 Non Alcoholic Steatohepatitis 55 Statin Drugs 55 RE MODEL 55 Colorectal Cancer Risk 55 Pivotal Phase III 55 carotid artery stenosis 55 Arterial Disease 55 Prostate Cancer Detection 55 Dose Response 55 intermittent claudication 55 Protein Linked 55 reinfarction 55 Placebo controlled 55 Reduces Mortality 55 HDL Cholesterol 55 antiarrhythmic drug 55 Iron Deficiency 55 Bone Fractures 55 Exacerbation 55 rFVIIa 55 Pivotal Clinical Trial 55 symptomatic intracranial 55 CIPN 55 Gastric Cancer 55 Malignant Glioma 55 Erectile Dysfunction Drug 55 Toremifene 54 Angioedema 54 Aortic Dissection 54 asymptomatic carotid stenosis 54 Percutaneous Tibial Nerve Stimulation 54 Mitral Regurgitation 54 Statin therapy 54 Acute Heart Failure 54 Peripheral Artery Disease 54 CABANA 54 Glufosfamide 54 Diabetic Nephropathy 54 EVEREST II 54 Renal Function 54 Chronic Inflammation 54 variceal bleeding 54 Systolic Hypertension 54 LUX Lung 54 Septic Shock 54 Chronic Myeloid Leukemia 54 Protease Inhibitors 54 HuMax EGFr 54 Diet Linked 54 EURIDIS 54 multicentre randomized 54 Lung Cancer Survival 54 Drug Shows Promise 54 gastro esophageal reflux 54 renal artery stenting 54 upper gastrointestinal bleeding 54 Evaluation WISE 54 Differential Diagnosis 54 deep vein thromboses 54 platelet inhibitor 54 Laparoscopic Adjustable Gastric Banding 54 colorectal adenoma 54 Bone Marrow Cells 54 Antidepressant Use 54 BCIRG 54 Randomized Comparison 54 afib 54 Myelodysplastic Syndromes 54 Migraine Headache 54 Alternative Treatments 54 NATRECOR R 54 Peptic Ulcer 54 Renal Cell Cancer 54 Double Blind Randomized 54 Electrical Stimulation 54 Pemetrexed 54 Fatty Liver Disease 54 Rheumatoid Arthritis RA 54 Osteoarthritis Patients 54 ExTRACT TIMI 54 Acute Pancreatitis 54 Artificial Pancreas 54 morphometric vertebral fractures 54 Acute Renal Failure 54 Suicidality 54 Hepatocellular Carcinoma 54 Ovarian Cancer Patients 54 Stress Urinary Incontinence 54 Stenting Trial CREST 54 Bone Marrow Transplants 54 Male Infertility 54 Hyperkalemia 54 PRECISE 54 Childhood Vaccinations 54 Sudden Cardiac Death 54 Adjuvant Therapy 54 CURRENT OASIS 7 54 Periodontal Treatment 54 Obese Patients 54 Claudication 54 Phase IIIb clinical 54 Pelvic Floor 54 pyridostigmine 54 juvenile idiopathic arthritis 54 Randomized Trials 54 Dose Ranging Study 54 Relapsed Refractory 54 Viral Infection 54 Low Dose 54 Diabetes Complications 54 Carotid artery 54 diuretics beta blockers 54 Peripheral Arterial Disease 54 Stroke Prevention 54 Pharmacologic 54 Treating Depression 54 Blood Pressure Lowering 54 multicenter multinational 54 testosterone supplementation 54 Osteoporosis Treatment 54 abdominal adiposity 54 RE LY ® 54 Attack Trial ALLHAT 54 oral anticoagulant therapy 54 RhuDex 54 Trandolapril 54 CYT# potent vascular disrupting 54 Gene Mutation Linked 54 Coronary Artery Calcium 54 Randomized Clinical Trials 54 CHOLESTEROL 54 AZILECT R 54 Natalizumab 54 Prospective Randomized Trial 54 RE LY 54 Lung Cancer Risk 54 Aliskiren 54 APPRAISE 54 Increased Mortality 54 Betaferon R 54 TAXUS ATLAS 54 Multicenter Trial 54 Postmenopausal Women 54 claudication 54 Multicenter Randomized Double 54 conjugated estrogens 54 NIDDM 54 Prostate Cancer Patients 54 Antiviral Therapy 54 #-# Full Text 54 II Clinical Trial 54 SABCS 54 Kidney Transplant Patients 54 Long Lesion 54 ISAR TEST 54 Aggressive Drug Evaluation 54 Rectal Cancer 54 Antipsychotic Medications 54 Primary Hypercholesterolemia 54 Multicenter 54 Meets Primary Endpoint 54 Oral Mucositis 54 Blood Pressure Drugs 53 Ovarian Cancer Risk 53 Abdominal Aortic Aneurysms 53 Insulin Pumps 53 Carotid Endarterectomy 53 Analytical Tool 53 Gastric Bypass Surgery 53 Trigeminal Neuralgia 53 Autoimmune Disease 53 NCCTG N# 53 Degarelix 53 chromium supplementation 53 Low Incidence 53 Severe Acne 53 thromboembolic complications 53 recurrent DVT 53 Enhanced External Counterpulsation 53 Allergic Rhinitis 53 ENDEAVOR III 53 Progenitor Cells 53 Prostate Cancer Risk 53 Stomach Cancer 53 Carvedilol 53 Sleep Disordered Breathing 53 Obesity Linked 53 ACTEMRA TM 53 Clinical Trial Results 53 calcaneal fractures 53 Treatment Reduces 53 venous thromboembolic disease 53 Heavy snorers 53 hyperacute 53 See WARNINGS 53 Endarterectomy 53 Pulmonary Embolism PE 53 Clinical Trial Data 53 Neurologic Disorders 53 number NCT# ClinicalTrials.gov 53 Prostate Cancer Progression 53 antihypertensive therapy 53 Myocardial 53 Phase IIb Trial 53 Shoulder Pain 53 Migraine Pain 53 subtrochanteric 53 Lowering Blood Pressure 53 Eisenmenger syndrome 53 Postmarketing 53 Polyneuropathy 53 Renal Impairment 53 Stress Fractures 53 Study Evaluating 53 Prolongs Life 53 Hospital Acquired Pneumonia 53 Disease Modifying 53 EFFEXOR XR 53 CLARITY study 53 Echocardiographic 53 Aortic Valve Replacement 53 Inflammatory Markers 53 Treating Prostate Cancer 53 pertuzumab 53 Predict Prostate Cancer 53 Tumor Progression 53 Prostate Screening 53 evaluating mipomersen 53 LIFELONG HEALTH 53 ACCORD Lipid 53 IIa Clinical Trial 53 Hypoglycaemia 53 Lung Cancer Patients 53 thromboembolic events 53 GASTRIC 53 Safinamide 53 ONTARGET 53 superficial vein thrombosis 53 trials RCTs 53 Atomoxetine 53 Androgen Deprivation 53 Uterine Fibroid 53 Asthma Symptoms 53 Prostate Biopsy 53 Kidney Function 53 immunomodulatory agents 53 Multicentre 53 STOP AF 53 Sibutramine Cardiovascular Outcomes 53 Torsades de Pointes 53 Brain Atrophy 53 vein thrombosis 53 Ventricular Tachycardia 53 See CONTRAINDICATIONS 53 Tipranavir 53 Comorbidities 53 Coronary Artery 53 variceal 53 Hypercholesterolemia 53 leukotriene receptor antagonists 53 Celebrex celecoxib 53 MADIT 53 Pharmacokinetic Study 53 Cognitive Problems 53 aldosterone antagonists 53 Irbesartan 53 anticoagulant medications 53 Lucentis ranibizumab Genentech 53 Suicidal Ideation 53 Delayed Graft Function 53 R lenalidomide 53 Pre Exposure Prophylaxis 53 Cardiogenic Shock 53 Neuroprotective Effects 53 Prehypertension 53 Help Smokers Quit 53 Antidepressants Linked 53 Lung Cancers 53 Blood Glucose 53 Lupus Nephritis 53 ivabradine 53 HIV HCV coinfected 53 warfarin therapy 53 Biolimus A9 53 thromboprophylaxis 53 preterm neonates 53 lymphedema swelling 53 mycophenolate mofetil 53 Glycemic Control 53 Breast Biopsies 53 Legg Calvé Perthes disease 53 undergoing Percutaneous Coronary 53 Secondary Hyperparathyroidism 53 Prostate Cancer Survival 53 PAOD 53 Morbid Obesity 53 Calcium Vitamin D 53 Myocardial Infarction TIMI 53 Coronary Revascularization 53 subclinical hypothyroidism 53 ischemic complications 53 Demonstrates Positive 53 antiplatelet drugs 53 CALERIE 53 Teva Provides Update 53 Insulin Sensitivity 53 Menopausal Symptoms 53 oral FTY# 53 Varicose Veins 53 dermatologic reactions 53 Fibrates 53 GP IIb IIIa inhibitors 53 thromboembolic disease 53 Tyrosine Kinase Inhibitor 53 GUSTO 53 Phase III Trial 53 Dupuytren Contracture 53 Stem Cell Treatment 53 MEVACOR 53 bullous 53 Premenopausal Women 53 CAMMS# 53 Menstrual Cramps 53 Novel Oral 53 Idiopathic Pulmonary Fibrosis 53 Renal Failure 53 Breast Cancer Risk 53 reperfusion injury 53 Renal dysfunction 53 Causes Symptoms 53 Mimetics 53 Phase IIIb 53 Preclinical Evaluation 53 Obese Teens 53 beta blocker therapy 53 Thyroid Cancer 53 CLARITY TIMI 53 Tumor Response 53 Folic Acid Supplements 53 BARI 2D 53 Acid Reflux 53 Randomized Placebo Controlled 53 CT Angiography 53 Brain Shrinkage 53 Cardiac Disease 53 Teriparatide 53 Calcium Supplements 53 pulmonary dysfunction 53 Hematological 53 milrinone 53 carotid stenosis 53 Knee Replacement Surgery 53 Lymphocytic 52 Myocardial Infarction 52 antiplatelet medication 52 Parnate 52 Clinical Trial Evaluating 52 Tocilizumab 52 randomized multicenter 52 intracerebral hemorrhage ICH 52 Antitumor Activity 52 JAK Inhibitor 52 Recurrent Prostate Cancer 52 Sleep Duration 52 Drug Coated Stents 52 lipid lowering drugs 52 Inflammatory Arthritis 52 Infliximab 52 Ocrelizumab 52 Eases Pain 52 Calcium Intake 52 Heart Attacks 52 malignant ascites 52 diabetic polyneuropathy 52 Microalbuminuria 52 Previously Treated 52 medial tibial stress 52 Pre Eclampsia 52 Glucose Metabolism 52 Outpatient Setting 52 Idiopathic 52 ECASS 52 Breast Cancer Patients 52 Boosts Survival 52 Metabolic Endocrinology 52 APTIVUS R 52 J Am Coll 52 postoperative atrial fibrillation 52 Investigational Agent 52 ACTIVE W 52 Golimumab 52 Survival Rates 52 Brain Scans 52 carotid atherosclerosis 52 Angina 52 intracranial stenosis 52 Clinical Evaluation 52 Rheumatic Fever 52 extracorporeal shock wave 52 Dose Escalation 52 thromboses 52 Acne Drug 52 Vidaza azacitidine 52 knee osteoarthritis OA 52 cilostazol 52 abacavir Ziagen 52 perioperatively 52 HORIZONS AMI 52 Cardiac Arrhythmias 52 cerebrovascular events 52 Aggressive Prostate Cancer 52 Urinary Incontinence 52 Treated Patients 52 ADHF 52 Generalized Anxiety Disorder 52 recurrent miscarriage 52 SCD HeFT 52 Stem Cell Transplants 52 TORISEL TM 52 Predict Breast Cancer 52 nonvertebral 52 Blood Flow 52 anticlotting drugs 52 Chronic Renal Failure 52 Glatiramer Acetate 52 infliximab Remicade 52 degenerative spondylolisthesis 52 PFO migraine 52 candesartan cilexetil 52 Antihypertensive 52 Prevent Breast Cancer 52 Pioglitazone 52 Gene Mutation 52 Pramlintide 52 Arteriosclerosis 52 Clinical Efficacy 52 HoFH 52 Estrogen deficiency 52 Blood Cancers 52 RENAL 52 nonvertebral fractures 52 multicenter randomized clinical 52 Risk Stratification 52 Intravenous Formulation 52 cinacalcet 52 Osteopenia 52 Hypertriglyceridemia 52 ARBITER 52 diabetic kidney 52 phase IIb study 52 COR Diabetes 52 Regimens 52 Thyroid Hormone 52 Chronic Bronchitis 52 STENT 52 intracerebral 52 Cognitive Deficits 52 Test Detects 52 HeFH 52 Treatment Regimen 52 Heavy Menstrual Bleeding 52 Randomized Controlled 52 parathyroidectomy 52 glucocorticoid therapy 52 cutaneous squamous cell carcinoma 52 Autologous Stem Cell Transplantation 52 deferiprone 52 Menopause Symptoms 52 Desvenlafaxine Succinate 52 PYY #-# 52 Raynaud Disease 52 Pivotal Trials 52 angiotensin II receptor blockers 52 ToGA 52 renal artery stenosis 52 Restless Legs 52 proliferative retinopathy 52 Muscle Function 52 antithrombotic therapy 52 loop diuretics 52 lichen planus 52 Strongly Linked 52 paroxysmal atrial fibrillation 52 Guidelines Issued 52 Hemodialysis Patients 52 canakinumab 52 ORENCIA ® 52 AIM HIGH 52 Long Term Survival 52 HoLEP 52 Inflammatory Response 52 cediranib 52 prolonged QT interval 52 Etanercept 52 Chronic Insomnia 52 Bladder Control 52 Psychiatric Disorders 52 Acute myocardial infarction 52 multicenter prospective 52 osteoporotic vertebral fractures 52 undergoing radical prostatectomy 52 Lumbar Spine 52 MS relapses 52 Reduce Mortality 52 Chronic Cough 52 cancerous colon polyps 52 Anti Clotting Drug 52 Suffer Depression 52 prostate TURP 52 velafermin 52 Sexual Satisfaction 52 Erythropoietic 52 Menopausal Women 52 antithrombotic therapies 52 Left Ventricular Dysfunction 52 Cyclooxygenase 2 52 Coronary Artery Disease 52 bevacizumab Avastin 52 Demonstrates Potent 52 Uric Acid 52 NATRECOR ® 52 Prostate Specific Antigen 52 Catheterization 52 Blood Vessels 52 Decitabine 52 Pulmonary Arterial Hypertension 52 Heart Ailments 52 symptomatic carotid stenosis 52 Cimzia TM 52 flecainide 52 Aerobic Exercise 52 Reperfusion 52 Tigecycline 52 Acute Coronary Syndrome 52 intensive statin therapy 52 Alfimeprase 52 Chest discomfort 52 Epilepsy Drugs 52 reflux symptoms 52 Iron Overload 52 Bioequivalence 52 Active Ulcerative Colitis 52 Premature Babies 52 Phase Ib Clinical Trial 52 venous hypertension 52 nicardipine 52 hallux rigidus 52 Aromatase Inhibitors 52 periprocedural 52 REALITY Trial 52 intracerebral haemorrhage 52 Osteoporosis Drug 52 Insulin detemir 52 Breast Cancer Survival 52 CABG Surgery 52 Achieves Primary Endpoint 52 postoperative pulmonary 52 SPIRIT FIRST 52 Phase III Trials 52 Late Breaker 52 AVAPRO 52 Lipid Lowering Treatment 52 Immune Mediated 52 Inhaled Steroids 52 peritoneal cancer 52 overactive bladder symptoms 52 Myocarditis 52 Occlusive Disease 52 MULTAQ 52 osteoporotic compression fractures 52 Nymox NX 52 Cardiac Outcomes 52 glatiramer acetate 52 COPD Exacerbations 52 Remission Maintenance 52 Controlled Study 52 duplex ultrasonography 52 thrombotic complications 52 ropinirole 52 Prostate AdenoCarcinoma Treatment 52 Irritable Bowel Syndrome IBS